By Brazil Stock Guide – YDUQS Participações S.A. (B3: YDUQ3), a leading Brazilian private higher education group, reported third-quarter 2025 results that surpassed market expectations, fueled by exceptional cash generation, robust performance in its premium units, and a significant reduction in leverage, showcasing resilience amid a high-interest-rate environment.
The company posted a net income of R$97.9 million (US$18 million), a decrease of 35.5% compared to 3Q24, primarily impacted by a R$63.6 million deterioration in the financial result due to higher Selic rates. However, adjusted EBITDA grew 5.8% to R$507.7 million (US$93 million), with the margin expanding by 1.0 percentage point to 37.6%. Net revenue increased 3.5% to R$1.35 billion (US$248 million). A key highlight was the R$559.5 million Free Cash Flow to Equity (FCFE) generated in the first nine months of 2025, already reaching the full-year guidance range, and a reduction in net debt/EBITDA leverage to 1.52x from 1.54x a year earlier.
“The quarter’s robust cash generation, surpassing R$610 million in the last 12 months, is the clearest signal of the business’s ability to create value for shareholders, even in a period with share buybacks and dividend payments,” the management stated in its earnings release, emphasizing disciplined execution and a solid capital allocation policy.
The results arrive as the education sector navigates the implementation of Brazil’s new regulatory framework, which emphasizes teaching quality and in-person learning. YDUQS’s strategic focus on its high-margin Premium segment (Idomed and Ibmec), which now accounts for 31% of net revenue and 43% of EBITDA, positions it favorably. The stabilization of the on-campus student base after several quarters of contraction and the explosive growth of the semi-on-campus modality, which surpassed 100,000 students, also point to a successful adaptation to market shifts.
Looking ahead, the company reaffirmed its FCFE guidance of R$500-600 million for 2025. Analysts will monitor the continued migration of students from the old private financing model and the final approval of the Unifametro medical school acquisition, which would add 60 annual seats to its portfolio, for further upside potential.
Leave a Reply